Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial

NCT07413146 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT07413146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07413146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial
Lead sponsor
Sun Yat-sen University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 24, 2026
Completion date
July 31, 2027
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer (stage ii & iii), immunoscore, minimal residual disease, neoadjuvant chemotherapy